These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13940449)

  • 1. Correlation of hypotensive effects and urinary tryptamine levels during pargyline therapy.
    ORVIS HH; TAMAGNA IG; HORWITZ D; THOMAS R
    Ann N Y Acad Sci; 1963 Jul; 107():958-65. PubMed ID: 13940449
    [No Abstract]   [Full Text] [Related]  

  • 2. CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.
    LESSIN AW; LONG RF; PARKES MW
    Br J Pharmacol Chemother; 1965 Feb; 24(1):49-67. PubMed ID: 14301999
    [No Abstract]   [Full Text] [Related]  

  • 3. PARGYLINE HYDROCHLORIDE, HYPERTENSION, URINARY TRYPTAMINE, AND VASCULAR REFLEXES.
    WINSOR T
    Geriatrics; 1964 Aug; 19():598-605. PubMed ID: 14201417
    [No Abstract]   [Full Text] [Related]  

  • 4. N-Methyl-alpha-methyl-tryptamine: a potent monoamine oxidase inhibitor and tryptamine antagonist.
    TEDESCHI DH; TEDESCHI RE; FOWLER PJ; GREEN H; FELLOWS EJ
    Biochem Pharmacol; 1962 Jun; 11():481-5. PubMed ID: 13920062
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive properties of pargyline hydrochloride. New non-hydrazine monoamine oxidase inhibitor compared with sulphonamide diuretics.
    BRYANT JM; TOROSDAG S; SCHVARTZ N; FLETCHER L; FERTIG H; SCHWARTZ MS; QUAN RB
    JAMA; 1961 Oct; 178():406-9. PubMed ID: 13874134
    [No Abstract]   [Full Text] [Related]  

  • 6. EXPERIENCE WITH PARGYLINE HYDROCHLORIDE (NONHYDRAZINE MONOAMINE OXIDASE INHIBITOR) AS AN ANTIHYPERTENSIVE AGENT: PRELIMINARY OBSERVATIONS IN 32 PATIENTS.
    KAVANAUGH GJ; SHEPS SG; FAIRBAIRN JF; OSMUNDSON PJ; SCHIRGER A
    Minn Med; 1965 Jun; 48():731-5. PubMed ID: 14287386
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations on the antihypertensive effect of pargyline hydrochloride.
    SUTNICK AI; FEWELL JW; SOLOFF JA
    Am J Med Sci; 1963 Feb; 245():166-70. PubMed ID: 13979405
    [No Abstract]   [Full Text] [Related]  

  • 8. PARGYLINE HYDROCHLORIDE AS AN ANTIHYPERTENSIVE AGENT WITH AND WITHOUT A THIAZIDE.
    TOROSDAG S; SCHVARTZ N; FLETCHER L; FERTIG H; SCHWARTZ MS; QUAN RB; BRYANT JM
    Am J Cardiol; 1963 Dec; 12():822-7. PubMed ID: 14088219
    [No Abstract]   [Full Text] [Related]  

  • 9. A STUDY OF THE POTENTIATION OF TRYPTAMINE BY MONOAMINE OXIDASE INHIBITORS IN THE DOG.
    EBLE JN
    J Pharmacol Exp Ther; 1965 Apr; 148():48-53. PubMed ID: 14279183
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 11. URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
    LABROSSE EH; KOPIN IJ; FELIX WR; WESTLAKE RJ
    J Psychiatr Res; 1964 Oct; 2():185-97. PubMed ID: 14242376
    [No Abstract]   [Full Text] [Related]  

  • 12. PARGYLINE HYDROCHLORIDE AS AN ANTIHYPERTENSIVE AGENT.
    LEE RE
    Am Heart J; 1963 Dec; 66():833-4. PubMed ID: 14090325
    [No Abstract]   [Full Text] [Related]  

  • 13. POSSIBLE REACTION TO CHEESE AND CONCOMITANT PARGYLINE HYDROCHLORIDE THERAPY: REPORT OF A CASE.
    HUTCHISON JC; KENWORTHY HJ; STAMPS WH
    Curr Ther Res Clin Exp; 1964 Jan; 6():67-8. PubMed ID: 14105062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical-psychiatric experiences with ethyl tryptamine acetate].
    FISCHER PA
    Arztl Forsch; 1962 Aug; 16():I/429-31. PubMed ID: 13893160
    [No Abstract]   [Full Text] [Related]  

  • 15. TO-DAY'S DRUGS. PARGYLINE HYDROCHLORIDE.
    HIBBARD BM
    Br Med J; 1964 Jun; 1(5396):1489. PubMed ID: 14132089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antihypertensive effect of pargyline HCl with and without diuretic sulfonamides.
    BRYANT JM; SCHVARTZ N; TOROSDAG S; FERTIG H; FLETCHER L; SCHWARTZ MS; QUAN RB
    Ann N Y Acad Sci; 1963 Jul; 107():1023-32. PubMed ID: 14016427
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of pargyline hydrochloride in the treatment of hypertension.
    POLLACK PJ
    Curr Ther Res Clin Exp; 1963 May; 5():264-72. PubMed ID: 13971987
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of pargyline (Eutonyl) in private practice.
    KLINE NS
    Ann N Y Acad Sci; 1963 Jul; 107():1090-106. PubMed ID: 14033529
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.